Product Code: ETC8842168 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The market for geriatric medicines is expanding as the prevalence of age-related diseases, such as arthritis, dementia, and cardiovascular disorders, rises. Pharmaceutical companies are introducing specialized medications tailored to the healthcare needs of the elderly population.
The rising incidence of chronic diseases among the elderly, coupled with advancements in pharmaceutical research, is driving the geriatric medicines market. The growing demand for specialized medications tailored to age-related conditions is encouraging pharmaceutical companies to develop new products. Additionally, government healthcare programs aimed at improving senior citizen welfare are supporting market growth.
The geriatric medicines market in the Philippines faces challenges related to high medication costs, limited insurance coverage, and low accessibility in rural areas. Many essential medicines for elderly patients, including those for chronic conditions like arthritis and dementia, are expensive. Public health insurance does not always cover specialized geriatric treatments, making them inaccessible to lower-income groups. Additionally, rural areas often lack pharmacies and healthcare facilities that stock essential geriatric medicines.
The increasing prevalence of chronic diseases among the elderly has boosted demand for geriatric medicines. Investors can capitalize on pharmaceutical production, distribution, and retail opportunities catering to senior-specific healthcare needs. Collaborations with healthcare providers and insurance companies can strengthen market positioning.
The government regulates the geriatric medicines market through the Food and Drug Administration (FDA), ensuring that medications for the elderly meet safety and efficacy standards. Policies under the DOHs senior citizen healthcare initiatives promote affordable access to essential geriatric drugs. The Philippine Health Insurance Corporation (PhilHealth) provides subsidies for prescription medications for senior citizens. Additionally, government initiatives encourage pharmaceutical companies to invest in research and development for age-related diseases.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Geriatric Medicines Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Geriatric Medicines Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Geriatric Medicines Market - Industry Life Cycle |
3.4 Philippines Geriatric Medicines Market - Porter's Five Forces |
3.5 Philippines Geriatric Medicines Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Philippines Geriatric Medicines Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Philippines Geriatric Medicines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Philippines Geriatric Medicines Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Philippines Geriatric Medicines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Philippines Geriatric Medicines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Geriatric Medicines Market Trends |
6 Philippines Geriatric Medicines Market, By Types |
6.1 Philippines Geriatric Medicines Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Philippines Geriatric Medicines Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Philippines Geriatric Medicines Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.1.4 Philippines Geriatric Medicines Market Revenues & Volume, By Arthritis, 2021- 2031F |
6.1.5 Philippines Geriatric Medicines Market Revenues & Volume, By Diabetes, 2021- 2031F |
6.1.6 Philippines Geriatric Medicines Market Revenues & Volume, By Neurological, 2021- 2031F |
6.1.7 Philippines Geriatric Medicines Market Revenues & Volume, By Cancer, 2021- 2031F |
6.1.8 Philippines Geriatric Medicines Market Revenues & Volume, By Osteoporosis, 2021- 2031F |
6.1.9 Philippines Geriatric Medicines Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Philippines Geriatric Medicines Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Philippines Geriatric Medicines Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Philippines Geriatric Medicines Market Revenues & Volume, By Analgesic, 2021- 2031F |
6.2.3 Philippines Geriatric Medicines Market Revenues & Volume, By Antihypertensive, 2021- 2031F |
6.2.4 Philippines Geriatric Medicines Market Revenues & Volume, By Statins, 2021- 2031F |
6.2.5 Philippines Geriatric Medicines Market Revenues & Volume, By Antidiabetic, 2021- 2031F |
6.2.6 Philippines Geriatric Medicines Market Revenues & Volume, By Proton Pump Inhibitor, 2021- 2031F |
6.2.7 Philippines Geriatric Medicines Market Revenues & Volume, By Anticoagulant, 2021- 2031F |
6.3 Philippines Geriatric Medicines Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Philippines Geriatric Medicines Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Philippines Geriatric Medicines Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Philippines Geriatric Medicines Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Philippines Geriatric Medicines Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Philippines Geriatric Medicines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Philippines Geriatric Medicines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Philippines Geriatric Medicines Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.4.5 Philippines Geriatric Medicines Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Philippines Geriatric Medicines Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Philippines Geriatric Medicines Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Philippines Geriatric Medicines Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Philippines Geriatric Medicines Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Philippines Geriatric Medicines Market Import-Export Trade Statistics |
7.1 Philippines Geriatric Medicines Market Export to Major Countries |
7.2 Philippines Geriatric Medicines Market Imports from Major Countries |
8 Philippines Geriatric Medicines Market Key Performance Indicators |
9 Philippines Geriatric Medicines Market - Opportunity Assessment |
9.1 Philippines Geriatric Medicines Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Philippines Geriatric Medicines Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Philippines Geriatric Medicines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Philippines Geriatric Medicines Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Philippines Geriatric Medicines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Philippines Geriatric Medicines Market - Competitive Landscape |
10.1 Philippines Geriatric Medicines Market Revenue Share, By Companies, 2024 |
10.2 Philippines Geriatric Medicines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |